AbbVie Shares Drop 6% Amid Concerns About Humira (NYSE:ABBV) Sales Slump
vzfotos AbbVie Stock (New York Stock Exchange: ABBV) fell 6% in afternoon trading Friday in the wake of the drugmaker's ...
Tag: NYSEABBV
Survey Reveals GLP-1 Users More Likely to Undergo Cosmetic Procedures (NYSE:ABBV)
Svitlana Hulkó Users of GLP-1 drugs such as Ozempic, Wegovy and Zepbound are more likely to undergo cosmetic procedures, which ...
Next big wave of patent cliffs ahead; biopharmaceutical M&A expected to increase (NYSE:ABBV)
Olivier LeMoal With a significant number of blockbuster drugs at risk of losing market exclusivity in the next five years, ...
AbbVie’s global bestseller Humira will face imitations this week (NYSE:ABBV)
vzphotos After generating $208 billion in sales over two decades, AbbVie's (New York Stock Exchange: ABBV) the monopoly on its ...
Recommended.
